Delcath stock.

united states. securities and exchange commission. washington, d.c. 20549 . form 10-q

Delcath stock. Things To Know About Delcath stock.

Delcath Systems to raise $5M in stock and warrants offering SA News Mon, Jul. 18, 2022. Delcath Systems GAAP EPS of -$1.00 misses by $0.12, revenue of $0.38M beats by $0.07MDelcath Systems (NASDAQ:DCTH) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better business?We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional …Earnings for Delcath Systems are expected to grow in the coming year, from ($2.43) to ($1.45) per share. Delcath Systems has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 25th, 2024 based off prior year's report dates. Read More.Insider Buying: Delcath Systems, Inc. (NASDAQ:DCTH) COO Purchases $49,897.20 in Stock Ticker Report • about 1 month ago Delcath Systems, Inc. (NASDAQ:DCTH Get Free Report) COO John Purpura acquired 14,505 shares of the stock in a transaction dated Friday, October 13th. Roger Stoll DCTH stock SEC Form 4 insiders trading. Roger has made over 6 trades of the Delcath Systems stock since 2009, according to the Form 4 filled with the SEC. Most recently he bought 4,900 units of DCTH stock worth $8,575 on 28 September 2018.. The largest trade he's ever made was buying 25,000 units of Delcath Systems …

Nov 6, 2023 · On Friday, Delcath Systems Inc [NASDAQ:DCTH] saw its stock fall -2.50% to $3.12. On the same session, the stock had its day’s lowest price of $3.05, but rose to a high of $3.32. Over the last five days, the stock has lost -4.88%. Delcath Systems Inc shares have fallen nearly -13.33% since the year began. Nov 30, 2023 · Get Delcath Systems Inc (DCTH.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Get the latest Delcath Systems, Inc. (DCTH) stock news and headlines to help you in your trading and investing decisions.

Delcath Systems, Inc. is an interventional oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company's proprietary products, HEPZATO Kit (melphalan hydrochloride for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to ...

Research Reports. SEC Filings. Find the latest Delcath Systems, Inc. (DCTH) stock quote, history, news and other vital information to help you with your stock trading and investing.Delcath. About Us. Our Therapy. Clinical Trials. Investors. Contact. Delcath is dedicated to revolutionizing the treatment of cancer patients with the newest liver directed treatment for metastatic ocular melanoma.The FDA approved Delcath Systems Inc's DCTH HEPZATO KIT (melphalan/Hepatic Delivery System).. The approval is as a liver-directed treatment for adult patients with metastatic uveal melanoma with ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Stock split history for Delcath Systems since 2002. Prices shown are actual historical values and are not adjusted for either splits or ...

Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the ...

When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...As a result of this settlement, Delcath increased its number of directors to seven, appointed Ladd as an independent director, filled one of the open board seats with one of Ladd's nominees, secured the resignation of one of the board members who had been re-elected at the June, 2006, shareholder meeting, and delivered stock to Laddcap …Top movers analysis one hour before the close of the markets on 2023-08-15: top gainers and losers in today's session.See the latest Delcath Systems Inc stock price (DCTH:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Nov 22, 2023 · Delcath Systems stock has received a consensus rating of buy. The average rating score is and is based on 9 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Delcath ...

0001564590-17-016205.txt : 20170808 0001564590-17-016205.hdr.sgml : 20170808 0001564590-17-016205.hdr.sgml : 20170808Aug. 14, 2023 at 5:32 p.m. ET on Benzinga.com. DCTH | Complete Delcath Systems Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Sep 1, 2023 · Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today that it raised approximately $35 ...

Delcath has undergone numerous cap raises over its three decades of history but almost as numerous reverse stock splits have kept the share count to about 11 million. The market cap is $83 M ...Delcath Systems (). The second penny stock we’re looking at here is Delcath Systems, a biotech firm focused on interventional oncology. The company specializes in the development of minimally ...

Delcath stock began sliding April 30, after the FDA issued a briefing critical of the Melblez Kit and saying additional clinical trials may be necessary. That day, it fell from $1.39 to 83 cents.DCTH : 2.70 (+10.20%) Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor Conference PR Newswire - Tue Oct 10, 7:30AM CDT. /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that ...NEW YORK, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary...NEW YORK, March 27, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic ...Checkout Delcath Systems Inc (DCTH) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether DCTH beat the street expectations or not?

Nov 22, 2023 · When we look at Delcath Systems Inc’s average trading volume, we note the 10-day average is 0.54 million shares, with the 3-month average coming to 413.15K. Analysts gave the Delcath Systems Inc (DCTH) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.00.

Historical daily share price chart and data for Delcath Systems since 2002 adjusted for splits and dividends. The latest closing stock price for Delcath Systems as of November 10, 2023 is 2.95.. The all-time high Delcath Systems stock closing price was 100000000.00 on May 02, 2002.; The Delcath Systems 52-week high stock price is 7.99, which is 170.8% …

Get the latest Delcath Systems Inc (DCTH) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and market outlook for the second quarter of 2023. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: DCTH is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week. Volatility Over Time: DCTH's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.Dec 1, 2023 · Delcath Systems, Inc. - Sell. Zacks' proprietary data indicates that Delcath Systems, Inc. is currently rated as a Zacks Rank 4 and we are expecting a below average return from the DCTH shares ... NEW YORK, Nov. 15, 2023 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ:DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic ...SETTLEMENT AGREEMENT, dated as of October 8, 2006 (this “Agreement”), by and between Delcath Systems, Inc., a Delaware corporation (“Delcath”), on the one hand, and Laddcap Value Partners LP, a Delaware limited partnership, Laddcap Value Advisors LLC, a Delaware limited liability company, Laddcap Value Associates LLC, a Delaware limited …Find the latest Delcath Systems, Inc. (DCTH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.What this means: Delcath Systems Inc (DCTH) gets an Overall Rank of 56, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.When we look at Delcath Systems Inc’s average trading volume, we note the 10-day average is 0.54 million shares, with the 3-month average coming to 413.15K. Analysts gave the Delcath Systems Inc (DCTH) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.00.DELCATH SYSTEMS, INC. (Name of Registrant as Specified In Its Charter) ROBERT B. LADD ...Delcath is dedicated to revolutionizing the treatment of patients with cancer in their liver. Delcath Systems, Inc. is a commercial-stage interventional oncology company aiming to be the leader in targeted, safe and effective minimally-invasive treatments for patients with cancers in the liver. Nov 23, 2023 · In other news, COO John Purpura bought 14,505 shares of Delcath Systems stock in a transaction dated Friday, October 13th. The stock was bought at an average price of $3.44 per share, for a total transaction of $49,897.20. Following the purchase, the chief operating officer now owns 41,526 shares of the company’s stock, valued at $142,849.44.

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): N/ADCTH Stock 12 Months Forecast. $18.33. (536.46% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Delcath Systems in the last 3 months. The average price target is $18.33 with a high forecast of $21.00 and a low forecast of $16.00. The average price target represents a 536.46% change from the last price of $2.88.NEW YORK, Jan. 19, 2016 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that the Company has reached a Special Protocol Assessment (SPA) agreement with the U.S. …15 thg 8, 2023 ... Delcath Systems (DCTH) stock is rocketing higher on Tuesday after getting an update from the FDA for its cancer treatment.Instagram:https://instagram. what is vmfxxretail futures tradingchatgpt stock picksvanguard federal money market interest rate Get Delcath Systems Inc (DCTH.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments dutch tulipmaniajimmy buffett jewelry Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for DCTH stock stock is $18, which predicts an increase of 530.47 ...Dec 1, 2023 · Delcath Systems, Inc. (NASDAQ:DCTH) released its quarterly earnings results on Monday, November, 13th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.51) by $0.10. The business earned $0.43 million during the quarter, compared to the consensus estimate of $0.68 million. online.barronsbooks This proxy statement is furnished to holders of common stock, $.01 per share, of Delcath Systems, Inc. (“Delcath” or the “Company”). The proxies are being solicited by the Board of Directors of Delcath for use at the 2009 Annual Meeting of Stockholders of Delcath to be held at 11:00 a.m. (Eastern Time) on Tuesday, June 9, 2009, at the Offices of Hughes …-----begin privacy-enhanced message----- proc-type: 2001,mic-clear originator-name: [email protected] originator-key-asymmetric ...Delcath Systems, Inc. (NASDAQ: DCTH) observed an upward trajectory in its stock value during the extended trading session on Tuesday. The after-hours market saw a 6.22% surge, elevating Delcath stock to $2.39. This positive movement partially offset the earlier 24.50% decline, settling the regular session at $2.25. The surge was instigated by ...